Belmont Global Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-10,000	Closed	-$127K	–	122
2014 Q2	$127K	Hold	10,000	–	–	0.09%	120
2014 Q1	$106K	Buy	+10,000	New	+$106K	0.09%	111